BGMS
BGMS
Bio Green Med Solution, Inc.Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $81K ▲ | $1.01M ▼ | $-988K ▲ | -1.22K% ▼ | $-1.31 ▼ | $-990.5K ▲ |
| Q2-2025 | $0 | $1.32M ▼ | $-1.32M ▼ | 0% | $-0.84 ▼ | $-1.31M ▲ |
| Q1-2025 | $0 | $5.04M ▲ | $-81K ▲ | 0% | $-0.09 ▲ | $-5.04M ▼ |
| Q4-2024 | $0 ▼ | $1.83M ▼ | $-3.05M ▼ | 0% ▲ | $-79.2 ▲ | $-1.89M ▲ |
| Q3-2024 | $10K | $2.19M | $-1.96M | -19.57K% | $-218.23 | $-2.18M |
What's going well?
The company finally generated some revenue after having none last quarter, and losses are shrinking. Cost cuts in R&D and overhead helped reduce the burn rate.
What's concerning?
Sales are tiny compared to massive expenses, and the company is still losing over $12 for every $1 sold. Heavy overhead and rising share count mean shareholders are getting diluted while the business remains deeply unprofitable.
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $3.84M ▼ | $8.16M ▲ | $1.06M ▲ | $7.1M ▲ |
| Q2-2025 | $4.28M ▲ | $4.4M ▲ | $770K ▲ | $3.63M ▲ |
| Q1-2025 | $3.45M ▲ | $3.73M ▼ | $672K ▼ | $3.06M ▲ |
| Q4-2024 | $3.14M ▲ | $4.09M ▼ | $6.27M ▼ | $-2.17M ▼ |
| Q3-2024 | $2.98M | $5.38M | $6.35M | $-970K |
What's financially strong about this company?
BGMS has far more cash than debt, very high liquidity, and a big increase in shareholder equity. The company can easily pay all its bills and has a very conservative capital structure.
What are the financial risks or weaknesses?
Receivables and inventory have grown quickly, which could mean cash is getting tied up or customers are paying slower. The jump in goodwill adds some risk if the acquired assets don't perform.
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $-988K ▲ | $-434K ▲ | $0 | $-3K ▼ | $-437K ▼ | $-434K ▲ |
| Q2-2025 | $-1.32M ▼ | $-1.06M ▲ | $0 | $1.88M ▼ | $825K ▲ | $-1.06M ▲ |
| Q1-2025 | $-81K ▲ | $-3.25M ▼ | $0 | $3.65M ▲ | $313K ▲ | $-3.25M ▼ |
| Q4-2024 | $-3.05M ▼ | $-1.36M ▲ | $0 | $1.61M ▲ | $155K ▲ | $-1.36M ▲ |
| Q3-2024 | $-1.96M | $-3.07M | $0 | $-1K | $-3.02M | $-3.07M |
What's strong about this company's cash flow?
Cash burn is shrinking, dropping by more than half this quarter. The company still has almost $3.8 million in cash, giving it some breathing room to improve operations.
What are the cash flow concerns?
Operations are not generating cash, and the business is still losing real money. Without new funding or a turnaround, cash will run out in less than a year.
5-Year Trend Analysis
A comprehensive look at Bio Green Med Solution, Inc.'s financial evolution and strategic trajectory over the past five years.
BGMS combines improving cost discipline and cash burn trends with a strategic shift into a business that already has an operating track record. The fire safety subsidiary, Fitters, offers an integrated platform with manufacturing, distribution, and monitoring services, anchored by decades of local market experience and strong client relationships. The group is asset‑light and carries no traditional financial debt, which simplifies its capital structure and avoids leverage‑related risk. Together, these factors create a foundation on which a more stable, service‑oriented industrial profile could potentially be built.
The most pressing risks are financial. The balance sheet has weakened to the point of negative equity and tight liquidity, with clear warnings about the company’s ability to continue as a going concern without additional funding. Historically, the legacy business has not proven it can generate meaningful revenue or profits, and the pivot to fire safety introduces integration and execution risk. Competitive pressures, the need to keep pace with technological change in fire protection, and potential constraints on future R&D or capital spending all add to the uncertainty. Any delay in strengthening the balance sheet or in realizing commercial benefits from the acquisition would magnify these vulnerabilities.
Looking ahead, BGMS is at an inflection point. The legacy financials describe a company that has been consuming capital without reaching commercial scale, but the acquisition of an established fire safety operator offers a plausible path to a more sustainable model. Near‑term outcomes will be dominated by two questions: can management secure sufficient capital to stabilize the balance sheet, and can the fire safety business deliver consistent, profitable growth under the BGMS umbrella. If both challenges are met, the profile of the company could shift materially over the next few years; if not, the current financial fragility may limit the time available to complete this transformation.
About Bio Green Med Solution, Inc.
https://www.bgmsglobal.com/A diversified company operating in both the fire protection and biopharmaceutical industries. It expanded its portfolio by acquiring Fitters Sdn. Bhd., a Malaysian fire protection products and services group. Focuses on advancing opportunities in biopharmaceutical research and fire safety solutions to create sustainable long-term shareholder value.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $81K ▲ | $1.01M ▼ | $-988K ▲ | -1.22K% ▼ | $-1.31 ▼ | $-990.5K ▲ |
| Q2-2025 | $0 | $1.32M ▼ | $-1.32M ▼ | 0% | $-0.84 ▼ | $-1.31M ▲ |
| Q1-2025 | $0 | $5.04M ▲ | $-81K ▲ | 0% | $-0.09 ▲ | $-5.04M ▼ |
| Q4-2024 | $0 ▼ | $1.83M ▼ | $-3.05M ▼ | 0% ▲ | $-79.2 ▲ | $-1.89M ▲ |
| Q3-2024 | $10K | $2.19M | $-1.96M | -19.57K% | $-218.23 | $-2.18M |
What's going well?
The company finally generated some revenue after having none last quarter, and losses are shrinking. Cost cuts in R&D and overhead helped reduce the burn rate.
What's concerning?
Sales are tiny compared to massive expenses, and the company is still losing over $12 for every $1 sold. Heavy overhead and rising share count mean shareholders are getting diluted while the business remains deeply unprofitable.
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $3.84M ▼ | $8.16M ▲ | $1.06M ▲ | $7.1M ▲ |
| Q2-2025 | $4.28M ▲ | $4.4M ▲ | $770K ▲ | $3.63M ▲ |
| Q1-2025 | $3.45M ▲ | $3.73M ▼ | $672K ▼ | $3.06M ▲ |
| Q4-2024 | $3.14M ▲ | $4.09M ▼ | $6.27M ▼ | $-2.17M ▼ |
| Q3-2024 | $2.98M | $5.38M | $6.35M | $-970K |
What's financially strong about this company?
BGMS has far more cash than debt, very high liquidity, and a big increase in shareholder equity. The company can easily pay all its bills and has a very conservative capital structure.
What are the financial risks or weaknesses?
Receivables and inventory have grown quickly, which could mean cash is getting tied up or customers are paying slower. The jump in goodwill adds some risk if the acquired assets don't perform.
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $-988K ▲ | $-434K ▲ | $0 | $-3K ▼ | $-437K ▼ | $-434K ▲ |
| Q2-2025 | $-1.32M ▼ | $-1.06M ▲ | $0 | $1.88M ▼ | $825K ▲ | $-1.06M ▲ |
| Q1-2025 | $-81K ▲ | $-3.25M ▼ | $0 | $3.65M ▲ | $313K ▲ | $-3.25M ▼ |
| Q4-2024 | $-3.05M ▼ | $-1.36M ▲ | $0 | $1.61M ▲ | $155K ▲ | $-1.36M ▲ |
| Q3-2024 | $-1.96M | $-3.07M | $0 | $-1K | $-3.02M | $-3.07M |
What's strong about this company's cash flow?
Cash burn is shrinking, dropping by more than half this quarter. The company still has almost $3.8 million in cash, giving it some breathing room to improve operations.
What are the cash flow concerns?
Operations are not generating cash, and the business is still losing real money. Without new funding or a turnaround, cash will run out in less than a year.
5-Year Trend Analysis
A comprehensive look at Bio Green Med Solution, Inc.'s financial evolution and strategic trajectory over the past five years.
BGMS combines improving cost discipline and cash burn trends with a strategic shift into a business that already has an operating track record. The fire safety subsidiary, Fitters, offers an integrated platform with manufacturing, distribution, and monitoring services, anchored by decades of local market experience and strong client relationships. The group is asset‑light and carries no traditional financial debt, which simplifies its capital structure and avoids leverage‑related risk. Together, these factors create a foundation on which a more stable, service‑oriented industrial profile could potentially be built.
The most pressing risks are financial. The balance sheet has weakened to the point of negative equity and tight liquidity, with clear warnings about the company’s ability to continue as a going concern without additional funding. Historically, the legacy business has not proven it can generate meaningful revenue or profits, and the pivot to fire safety introduces integration and execution risk. Competitive pressures, the need to keep pace with technological change in fire protection, and potential constraints on future R&D or capital spending all add to the uncertainty. Any delay in strengthening the balance sheet or in realizing commercial benefits from the acquisition would magnify these vulnerabilities.
Looking ahead, BGMS is at an inflection point. The legacy financials describe a company that has been consuming capital without reaching commercial scale, but the acquisition of an established fire safety operator offers a plausible path to a more sustainable model. Near‑term outcomes will be dominated by two questions: can management secure sufficient capital to stabilize the balance sheet, and can the fire safety business deliver consistent, profitable growth under the BGMS umbrella. If both challenges are met, the profile of the company could shift materially over the next few years; if not, the current financial fragility may limit the time available to complete this transformation.

CEO
Sing Ee Wong
Compensation Summary
(Year )
Upcoming Earnings
Ratings Snapshot
Rating : C+

